Eric Tomlinson

ERIC TOMLINSON is Chief Executive Officer of Altea Therapeutics. He has
extensive expertise in pharmaceutical and biotechnology drug and gene
delivery research and development. He established and led the worldwide
Advanced Drug Delivery Research Program for Ciba-Geigy Pharmaceuticals
(now Novartis) and, as Chief Executive Officer of GeneMedicine, Inc., he
was responsible for its venture financing, initial and secondary public
offerings, business partnerships and development of clinical products
for treatment of cancer, cardiovascular disease and neuromuscular
disorders